PHARMOS, a.s. made a net profit of CZK CZK 13.6 mil under revenues of CZK 10,628 mil in 2015, up 132% and -0.695%, respectively, when compared to the last year.
This translates into a net margin of 0.128%. Historically, the firm’s net margin reached an all time high of 0.191% in 2006 and an all time low of -0.193% in 2012. The average net margin in the last five years amounted to 0.033%.
On the operating level, EBITDA margin reached 0.291% and EBIT amounted to 0.488% of sales in 2015.
As far as PHARMOS, a.s.'s peers are concerned, Geco posted net and EBITDA margin of 1.23% and 1.67%, respectively in 2015.